slide-01 slide-02 Screen4

Technology Platform

image-01

VaxInnate's Technology Platform is revolutionizing how vaccines are created and produced.

Explore

Product Pipeline

image-02

Learn more about our vaccines currently in our development pipeline

View

In The News

17 Feb 2015 - VaxInnate Receives Extension of Contract from BARDA for Development of Seasonal and Pandemic Influenza Vaccines

- Allows for Non-Dilutive Funding of $53 Million – CRANBURY, NJ – February 17, 2015 – VaxInnate Corporation, a biotechnology firm pioneering a breakthrough vaccine technology, today announced that it has executed a contract modification with the U.S. Department of Health and Human Services, Biomedical Advanced Research and Development Authority (BARDA) to extend the base […]

Read